Alexander Labrunerie & Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $774K | Sell |
11,216
-35
| -0.3% | -$2.42K | 0.32% | 51 |
|
|
2025
Q1 | $781K | Buy |
11,251
+75
| +0.7% | +$5.21K | 0.34% | 51 |
|
|
2024
Q4 | $961K | Sell |
11,176
-65
| -0.6% | -$5.59K | 0.42% | 41 |
|
|
2024
Q3 | $1.34M | Sell |
11,241
-30
| -0.3% | -$3.57K | 0.61% | 35 |
|
|
2024
Q2 | $1.61M | Buy |
11,271
+7
| +0.1% | +$999 | 0.86% | 28 |
|
|
2024
Q1 | $1.45M | Buy |
+11,264
| New | +$1.45M | 0.81% | 28 |
|